| CGQGX | GWPDX | CGQGX / GWPDX | |
| Total Expense Ratio | 0.63 | 0.38 | 166% |
| Annual Report Gross Expense Ratio | 0.68 | 0.38 | 179% |
| Fund Existence | 7 years | 9 years | - |
| Gain YTD | 19.264 | 19.552 | 99% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 24.9B | 24.9B | 100% |
| Annual Yield % from dividends | 0.43 | 0.64 | 68% |
| Returns for 1 year | 10.27 | 10.63 | 97% |
| Returns for 3 years | 50.09 | 50.33 | 100% |
| Returns for 5 years | 34.76 | 34.57 | 101% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NACP | 49.42 | 0.45 | +0.91% |
| Impact Shares NAACP Minority Empwrmt ETF | |||
| GDEC | 37.40 | 0.03 | +0.09% |
| FT Vest U.S. Eq Mod Buffr ETF - Dec | |||
| VNIE | 24.20 | N/A | N/A |
| Vontobel International Equity Active ETF | |||
| PSQO | 20.78 | -0.03 | -0.12% |
| Palmer Square Credit Opportunities ETF | |||
| ARKG | 29.76 | -0.09 | -0.30% |
| ARK Genomic Revolution ETF | |||